JOHN NOTABARTOLO: Open Payments
NPI 1023096351 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101,429 in 149 payments from 14 companies in 2025. Trend: 2023 $63,529 · 2024 $85,148 · 2025 $101,429
Speaker / faculty: $75,350Travel & lodging: $22,252Food & beverage: $3,479Education: $348
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 89 | $99,984 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $325 |
| Arcutis Biotherapeutics, Inc. | 5 | $188 |
| Galderma Laboratories, L.P. | 11 | $180 |
| ABBVIE INC. | 9 | $156 |
| UCB, Inc. | 6 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| LEO Pharma Inc. | 4 | $76 |
| PFIZER INC. | 3 | $56 |
Products named: TREMFYA, Zoryve, NEMLUVIO, SKYRIZI, Bimzelx, ILUMYA, COSENTYX, CIBINQO.
Industry payments across NV — which companies pay providers there.
